Preparation and characterization of paclitaxel microspheres in situ gel and its antitumor efficacy by local injection.
10.19723/j.issn.1671-167X.2019.03.015
- Author:
Ying ZHAN
1
;
Yi Tian DU
1
;
Zhen Zhen YANG
1
;
Chun Li ZHANG
2
;
Xian Rong QI
1
Author Information
1. Department of Pharmaceutics, Peking University School of Pharmaceutical Sciences & Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Beijing 100191, China.
2. Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Antineoplastic Agents, Phytogenic;
Cell Line, Tumor;
Delayed-Action Preparations;
Mice;
Microspheres;
Paclitaxel
- From:
Journal of Peking University(Health Sciences)
2019;51(3):477-486
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:The current difficulties in the treatment of tumor include repeated administration and high recurrence rate after tumor resection. In order to reduce the number of doses, avoid side effects of chemotherapeutic drugs, suppress tumor growth and delay tumor recurrence after surgery, a temperature-sensitive in situ gel with paclitaxel microspheres (PTX/M gel) was prepared. PTX/M gel was administered by intratumoral injection once a month.
METHODS:First of all, paclitaxel microspheres (PTX/M) were prepared by emulsion solvent evaporation method. A laser particle size distribution analyzer was used to investigate the size, distribution, specific surface area of microspheres. Paclitaxel content was determined by high performance liquid chromatography (HPLC). Then encapsulation efficiency of paclitaxel was calculated and in vitro release characteristics were studied. Secondly, PTX/M gel was prepared by cold dissolution method. The phase transition temperature, elastic modulus, dissolution curve, correlation between dissolution and release were measured. Finally, U87 MG and 4T1 subcutaneous tumor models were established respectively to study the efficacy of PTX/M gel in suppressing tumor growth and delaying tumor recurrence after surgery.
RESULTS:The median diameter of the selected PTX/M was (32.24±1.09) μm, the specific surface area was (206.61±10.23) m2/kg, the encapsulation efficiency was 85.29%±1.34%, and the cumulative release percentage of paclitaxel from PTX/M was 33.56%±3.33% in one month. Phase transition temperature of PTX/M gel was 33 °C. The elastic modulus of PTX/M gel at 25 °C and 37 °C were 4.2×103 Pa and 18×103 Pa, respectively. The gel could stay in the body for up to 48 hours. It could be seen from the results of animal experiments that were compared with the saline group and the Taxol group, and the tumor-bearing mice of the PTX/M gel group had the slowest tumor growth (P<0.05). Similarly, in the tumor recurrence experiments, the mice of PTX/M gel group had the latest tumor recurrence after surgery.
CONCLUSION:As a local sustained-release preparation, PTX/M gel can effectively suppress tumor growth and delay postoperative recurrence of tumors. It has potential advantages in tumor treatment.
